New hope for kidney disease: Zigakibart's Long-Term safety under study

NCT ID NCT06858319

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times

Summary

This study looks at the long-term safety of a drug called zigakibart for adults with IgA nephropathy, a kidney disease. It is for people who have already finished a previous zigakibart study. Researchers will monitor side effects and check kidney function over 96 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune disease chronic kidney disease chronic renal failure syndrome Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications glomerular disorder glomerulonephritis IgA glomerulonephritis IgA nephropathy, susceptibility to, 1 immune system disorder kidney disorder Male Urogenital Diseases nephritis urinary system disorder Urogenital Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLOMERULAR DISEASE GLOMERULONEPHRITIS GLOMERULONEPHRITIS, IGA GLOMERULOPATHY IMMUNOGLOBULIN DISEASE KIDNEY DISEASES KIDNEY DISEASES, CHRONIC UROLOGICAL DISEASES

Contacts and locations

Locations

Colorado Kidney Care Nephrology
RECRUITING

Denver, Colorado, 80230, United States
Dallas Renal Group
RECRUITING

Dallas, Texas, 75230, United States
Dallas Renal Group
RECRUITING

Dallas, Texas, 75230, United States
Icahn School of Medicine at Mount Sinai
RECRUITING

New York, New York, 10029, United States
Knoxville Kidney Center Pllc
RECRUITING

Brentwood, Tennessee, 37027-4528, United States
NY Nephrology
RECRUITING

Clifton Park, New York, 12065, United States
Nephro Asso North Illinois Indiana
RECRUITING

Houston, Texas, 60521, United States
Nephrology Associates Of Central FL
RECRUITING

Orlando, Florida, 32806, United States
Novartis Investigative Site
RECRUITING

Caba, Buenos Aires, 3375, Argentina
Novartis Investigative Site
RECRUITING

La Plata, Buenos Aires, B1902COS, Argentina
Novartis Investigative Site
RECRUITING

Buenos Aires, Buenos Aires F.D., 1280, Argentina
Novartis Investigative Site
RECRUITING

Catamarca, Catamarca Province, K4700BTM, Argentina
Novartis Investigative Site
RECRUITING

Santa Fe, S3000EPV, Argentina
Novartis Investigative Site
RECRUITING

Kogarah, New South Wales, 2217, Australia
Novartis Investigative Site
RECRUITING

Toronto, Ontario, M4C5T2, Canada
Novartis Investigative Site
RECRUITING

Kuantan, Pahang, 25100, Malaysia
Novartis Investigative Site
RECRUITING

Kuala Lumpur, 59100, Malaysia
Novartis Investigative Site
RECRUITING

Cheonan, Chungcheongnam-do, 330-721, South Korea
Novartis Investigative Site
RECRUITING

Guri-si, Gyeonggi-do, 471-701, South Korea
Novartis Investigative Site
RECRUITING

Seongnam-si, Gyeonggi-do, 13620, South Korea
Novartis Investigative Site
RECRUITING

Seoul, Seoul, 03080, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.